ProteinQure

ProteinQure in its US$4 million Seed round

Client

ProteinQure

Value

US$4 million

Service

Emerging and High Growth Companies

Date Closed

Industry

Venture Capital

Lead Office

Toronto


 

On July 25, 2019, ProteinQure announced its US$4 million Seed round led by Felicis Ventures with participation from 8VC, Golden Ventures, iNovia, Global Founders Capital and angel investor Tom Williams. ProteinQure plans to use this financing to continue adding top interdisciplinary talent to their team and expanding their partnerships with industry leaders.

ProteinQure, a Toronto-based biotech firm, is combining quantum annealing and reinforcement learning to lower the cost and increase speed of the drug development. ProteinQure leverages new and upcoming advances in computing architectures, from high-performance GPUs, TPUs, and specialized circuits, all the way to quantum computers.

Osler, Hoskin, & Harcourt LLP advised ProteinQure with a team led by Chad Bayne, consisting of Justin Dharamdial and Horatiu Porime (Emerging and High Growth Companies).


Team
Chad Bayne
Key Contact

Chad Bayne

Partner, Emerging and High Growth Companies

Justin Dharamdial

Justin Dharamdial

Associate, Emerging and High Growth Companies

M. Horatiu Porime

M. Horatiu Porime

Associate, Emerging and High Growth Companies